166 related articles for article (PubMed ID: 8698683)
1. Body dysmorphic disorder: diagnosis and treatment of imagined ugliness.
Phillips KA
J Clin Psychiatry; 1996; 57 Suppl 8():61-4; discussion 65. PubMed ID: 8698683
[TBL] [Abstract][Full Text] [Related]
2. Recognizing and treating body dysmorphic disorder.
Grant JE; Phillips KA
Ann Clin Psychiatry; 2005; 17(4):205-10. PubMed ID: 16402752
[TBL] [Abstract][Full Text] [Related]
3. Body dysmorphic disorder. A guide for dermatologists and cosmetic surgeons.
Phillips KA; Dufresne RG
Am J Clin Dermatol; 2000; 1(4):235-43. PubMed ID: 11702368
[TBL] [Abstract][Full Text] [Related]
4. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.
Hollander E; Allen A; Kwon J; Aronowitz B; Schmeidler J; Wong C; Simeon D
Arch Gen Psychiatry; 1999 Nov; 56(11):1033-9. PubMed ID: 10565503
[TBL] [Abstract][Full Text] [Related]
5. Body dysmorphic disorder--a fear of imagined ugliness.
Jefferys DE; Castle DJ
Aust Fam Physician; 2003 Sep; 32(9):722-5. PubMed ID: 14524210
[TBL] [Abstract][Full Text] [Related]
6. Body dysmorphic disorder: clinical aspects and treatment strategies.
Phillips KA
Bull Menninger Clin; 1998; 62(4 Suppl A):A33-48. PubMed ID: 9810776
[TBL] [Abstract][Full Text] [Related]
7. Body dysmorphic disorder: a guide for primary care physicians.
Phillips KA; Dufresne RG
Prim Care; 2002 Mar; 29(1):99-111, vii. PubMed ID: 11856661
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic treatment of body dysmorphic disorder.
Phillips KA
Psychopharmacol Bull; 1996; 32(4):597-605. PubMed ID: 8993080
[TBL] [Abstract][Full Text] [Related]
9. Body dysmorphic disorder and depression: theoretical considerations and treatment strategies.
Phillips KA
Psychiatr Q; 1999; 70(4):313-31. PubMed ID: 10587987
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fluvoxamine in body dysmorphic disorder.
Phillips KA; Dwight MM; McElroy SL
J Clin Psychiatry; 1998 Apr; 59(4):165-71. PubMed ID: 9590666
[TBL] [Abstract][Full Text] [Related]
11. Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient.
Hollander E; Aronowitz BR
J Clin Psychiatry; 1999; 60 Suppl 9():27-31. PubMed ID: 10335677
[TBL] [Abstract][Full Text] [Related]
12. [Body dysmorphic disorder: insufficiently recognized].
Tuijl JP
Ned Tijdschr Geneeskd; 2006 Jan; 150(2):75-6. PubMed ID: 16440560
[TBL] [Abstract][Full Text] [Related]
13. Body dysmorphic disorder.
Veale D
Postgrad Med J; 2004 Feb; 80(940):67-71. PubMed ID: 14970291
[TBL] [Abstract][Full Text] [Related]
14. Body dysmorphic disorder: recognition and treatment.
Anderson RC
Plast Surg Nurs; 2003; 23(3):125-8; quiz 129. PubMed ID: 14666808
[TBL] [Abstract][Full Text] [Related]
15. [Body dysmorphic disorder--dysmorphophobia].
Jakubietz M; Jakubietz R; Grünert J
Zentralbl Chir; 2007 Feb; 132(1):38-43. PubMed ID: 17304434
[TBL] [Abstract][Full Text] [Related]
16. Body dysmorphic disorder: 30 cases of imagined ugliness.
Phillips KA; McElroy SL; Keck PE; Pope HG; Hudson JI
Am J Psychiatry; 1993 Feb; 150(2):302-8. PubMed ID: 8422082
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy and psychotherapy for body dysmorphic disorder.
Ipser JC; Sander C; Stein DJ
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD005332. PubMed ID: 19160252
[TBL] [Abstract][Full Text] [Related]
18. Thirty-three cases of body dysmorphic disorder in children and adolescents.
Albertini RS; Phillips KA
J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):453-9. PubMed ID: 10199118
[TBL] [Abstract][Full Text] [Related]
19. An open-label study of citalopram in body dysmorphic disorder.
Phillips KA; Najjar F
J Clin Psychiatry; 2003 Jun; 64(6):715-20. PubMed ID: 12823088
[TBL] [Abstract][Full Text] [Related]
20. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.
Phillips KA; McElroy SL; Dwight MM; Eisen JL; Rasmussen SA
J Clin Psychiatry; 2001 Feb; 62(2):87-91. PubMed ID: 11247107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
